Global Pharmacovigilance Systems and Governance
Design, oversight and continuous improvement of global pharmacovigilance systems across central functions, affiliates and external partners.
Expertise
Reinhold’s expertise is grounded in senior operational responsibility across pharmacovigilance, regulatory affairs, quality governance and international pharmaceutical operations. His work combines scientific judgement, regulatory accountability, global system oversight and practical leadership in situations where decisions must be clear, documented and defensible.
Clear governance matters most when systems are under pressure and decisions cannot wait.
Areas of expertise
These areas are closely connected. Effective pharmacovigilance depends on the interaction of governance, scientific assessment, regulatory compliance, quality systems, technology and leadership.
Oversight structures, regulatory duties, and baseline governance across markets.
Design, oversight and continuous improvement of global pharmacovigilance systems across central functions, affiliates and external partners.
Strategic and practical understanding of EU QPPV responsibilities, oversight duties and organisational positioning.
Governance, maintenance and strategic use of the PSMF as an evidence base for effective oversight.
Applying GVP principles and scientific rigor to risk-benefit evaluations.
Translation of Good Pharmacovigilance Practices and international regulatory requirements into sustainable, inspection-ready processes.
Governance of signal detection, validation, assessment, escalation and benefit-risk decision-making.
Strategic oversight of pharmacovigilance risk management and the role of risk minimisation in protecting patients.
Resilient operational workflows, inspection readiness, and safety data integrity.
Preparation of pharmacovigilance systems, teams and governance structures for audits and regulatory inspections.
Oversight of individual case safety reports, data quality, workflows, compliance and operational interfaces.
Regulatory expectations, operating models, quality oversight and the evolving role of technology.
Cross-functional alignment, validated technology adoption, and decision-making under uncertainty.
Management of interfaces between Pharmacovigilance, Quality, Regulatory Affairs, Medical Affairs and other business functions.
Responsible adoption of AI through governance, human oversight, validation, risk assessment and clear accountability.
Decision-making, accountability and clear communication in safety-critical and highly regulated organisations.
Perspective
Regulatory requirements set the floor, not the ambition. A strong safety organisation is distinguished by the quality of its reasoning: whether an assessment can be explained, evidenced and defended years later, and whether the people closest to the data are heard.
This perspective shapes how Reinhold approaches governance, leadership, teaching and writing in pharmacovigilance.
Make the basis for every assessment and decision visible and understandable.
Ensure assessments can be evidenced and defended years after the fact.
Stand behind the judgement, the process and the people closest to the data.
Application
Practical learning formats for pharmacovigilance, governance and leadership in regulated environments.
Learn moreTeaching that connects regulatory foundations with real operational decision-making.
Learn moreWriting on pharmacovigilance, management, leadership and responsible use of artificial intelligence.
Learn moreEnquiries
For training, speaking, academic collaboration or professional exchange, please get in touch.